Brief: Fusen Pharmaceutical Announces Acquisition Of 34% Stake In Weihai Rensheng Pharmaceutical Group
31/12/2020 14:14
Dec 31 (Reuters) - Fusen Pharmaceutical Company Ltd
1652.HK :
* UNIT ENTERED INVESTMENT FRAMEWORK AGREEMENT FOR
ACQUISITION OF
34% STAKE IN WEIHAI RENSHENG PHARMACEUTICAL GROUP CO
* UNDER AGREEMENT UNIT WILL LEND TO WEIHAI HAOYANG LOAN
PRINCIPAL
AMOUNT OF RMB90.0 MILLION
* CONSIDERATION FOR EQUITY INTEREST OF RMB153 MILLION
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2020/1231/2020123101931.pdf
Further company coverage: 1652.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusen Pharmaceutical
See all newsBrief: Fusen Pharmaceutical Logs HY Loss Attributable RMB13.6 Million
Brief: Fusen Pharmaceutical Says Doxazosin Mesylate Extended-Release Tablets Approved For Marketing In China
Brief: Fusen Pharmaceutical Says Peramivir Injection First Neuraminidase Inhibitor Approved In China For Intravenous Influenza Treatment
Brief: Fusen Pharmaceutical Says Investors To Contribute RMB300 Mln For 34% Stake Subscription Of Henan Fusen Pharmaceutical
Brief: Fusen Pharmaceutical Says Piracetam Injection Approved For Marketing By NMPA